Literature DB >> 11311559

Identification, tissue expression, and chromosomal position of a novel gene encoding human ubiquitin-conjugating enzyme E2-230k.

T Yokota1, H Nagai, H Harada, N Mine, Y Terada, H Fujiwara, A Yabe, K Miyazaki, M Emi.   

Abstract

Through large-scale human genome mapping and sequencing of a region at chromosome 17q25.1 that is of particular interest because genes associated with breast, ovarian, and esophageal cancer are likely to be located there, we isolated the cDNA of a novel member of the family of ubiquitin-conjugating enzymes. The predicated peptide showed 97% identity in amino-acid sequence to murine ubiquitin-conjugating enzyme E2-230k (Mus UBE2-230k). The human cDNA consisted of 4878 nucleotides with an open reading frame encoding 1138 amino acids; the approximately 5 kb transcript was expressed predominantly in skeletal muscle and heart. The predicted UBE2-230k peptide contained a motif typical of the UBC domain that has been implicated in the ubiquitin-dependent proteolytic system and related pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311559     DOI: 10.1016/s0378-1119(01)00407-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

1.  A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity.

Authors:  Isabelle K Vila; Mi Kyung Park; Stephanie Rebecca Setijono; Yixin Yao; Hyejin Kim; Pierre-Marie Badin; Sekyu Choi; Vihang Narkar; Sung-Woo Choi; Jongkyeong Chung; Cedric Moro; Su Jung Song; Min Sup Song
Journal:  JCI Insight       Date:  2019-07-11

2.  UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination.

Authors:  Meilin Ma; Changhui Zhang; Rong Cao; Dongmei Tang; Xiongbo Sang; Sailan Zou; Xiuxuan Wang; Haixia Xu; Geng Liu; Lunzhi Dai; Yan Tian; Xiang Gao; Xianghui Fu
Journal:  Oncogene       Date:  2022-10-22       Impact factor: 8.756

3.  High Level of Ubiquitin Conjugate Enzyme E2O Indicates Poor Prognosis of Patients with Hepatocellular Carcinoma.

Authors:  Si-Yu Lan; Yang Ding; Chun Wang; Jun Fang; Chao Ren; Jia-Liang Liu; Hui Kang; Ying Chang
Journal:  Curr Med Sci       Date:  2022-10-21

4.  UBE2O negatively regulates TRAF6-mediated NF-κB activation by inhibiting TRAF6 polyubiquitination.

Authors:  Xiaofei Zhang; Juan Zhang; Long Zhang; Hans van Dam; Peter ten Dijke
Journal:  Cell Res       Date:  2013-02-05       Impact factor: 25.617

5.  Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6.

Authors:  Xiaofei Zhang; Juan Zhang; Andreas Bauer; Long Zhang; Douglas W Selinger; Chris X Lu; Peter Ten Dijke
Journal:  EMBO J       Date:  2013-03-01       Impact factor: 11.598

6.  UBE2O Promotes Progression and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.

Authors:  Xiyu Chen; Shuiting Zhang; Chao Liu; Guo Li; Shanhong Lu; Yunyun Wang; Xin Zhang; Donghai Huang; Yuanzheng Qiu; Yong Liu
Journal:  Onco Targets Ther       Date:  2020-06-29       Impact factor: 4.147

Review 7.  Role of E2-Ub-conjugating enzymes during skeletal muscle atrophy.

Authors:  Cecile Polge; Didier Attaix; Daniel Taillandier
Journal:  Front Physiol       Date:  2015-03-10       Impact factor: 4.566

Review 8.  New Insights into the Role of E2s in the Pathogenesis of Diseases: Lessons Learned from UBE2O.

Authors:  Daniel Hormaechea-Agulla; Youngjo Kim; Min Sup Song; Su Jung Song
Journal:  Mol Cells       Date:  2018-03-20       Impact factor: 5.034

Review 9.  Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Kiavash Hushmandi; Mahshad Kalantari; Reza Mohammadinejad; Tahereh Javaheri; Gautam Sethi
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

10.  UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.

Authors:  Xu Liu; Fei Ma; Chunxiao Liu; Kaiyuan Zhu; Wenjie Li; Yuting Xu; Ge Li; Zhenbo Niu; Jiaxin Liu; Du Chen; Zhigao Li; Yingqiang Fu; Cheng Qian
Journal:  Cell Death Dis       Date:  2020-01-06       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.